Epidermal Growth Factor Receptor Variant III Mutation, an Emerging Molecular Marker in Glioblastoma Multiforme Patients: A Single Institution Study on the Indian Population-Reference-Cited by-同舟云学术

Epidermal Growth Factor Receptor Variant III Mutation, an Emerging Molecular Marker in Glioblastoma Multiforme Patients: A Single Institution Study on the Indian Population

Published:2022-06-29 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Garima Garima,Thanvi Sharad,Singh Anurag,Verma Vijay

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference41 articles.

2. The somatic genomic landscape of glioblastoma;Brennan CW;Cell,2013

3. Epidermal growth factor ligand-independent, unregulated, cell-transforming potential of a naturally occurring human mutant EGFRvIII gene;Batra SK;Cell Growth Differ,1995

4. Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas;Sugawa N;Proc Natl Acad Sci U S A,1990

5. A deletion mutation within the ligand binding domain is responsible for activation of epidermal growth factor receptor gene in human brain tumors;Yamazaki H;Jpn J Cancer Res,1990

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches;Frontiers in Pharmacology;2024-03-08

2. Targeted Inhibitors of EGFR: Structure, Biology, Biomarkers, and Clinical Applications;Cells;2023-12-25

3. Digging the intercellular crosstalk via extracellular vesicles: May exosomes be the drug delivery solution for target glioblastoma?;Journal of Controlled Release;2023-06